Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Am Med Dir Assoc. 2019 Jun 18;20(12):1535–1539.e3. doi: 10.1016/j.jamda.2019.04.019

Table A3.

Baseline sample characteristics in cases with at least 2 visits and their matched controls

Mild cognitive impairment/Alzheimer’s disease
(n=53)
Age- and sex- matched controls
(n=106)
p value
Mean [SD] or No. (%)
Demographics
Age, years 79.4 [6.0] 79.5 [5.9] 0.955
Women 24 (45) 58 (45) 0.999
Black 10 (19) 11 (10) 0.144
Body mass index, kg/m2 25.9 [3.9] 25.7 [3.3] 0.655
Education, years 17 [4] 17 [3] 0.418
Average number of visits 3.6 [1.4] 4.5 [1.8] <0.001*
Average years of follow-up 5.8 [2.2] 5.6 [2.4] 0.681
Age at onset 85.2 [5.7] 85.1 [5.5] 0.912
Lap time variation, sec 0.945 [0.444] 0.846 [0.404] 0.161
Covariates
Fast gait speed over 400m, m/sec 1.34 [0.26] 1.43 [0.20] 0.024*
6-meter usual gait speed, m/sec 1.03 [0.21] 1.08 [0.19] 0.150
6-meter rapid gait speed, m/sec 1.55 [0.36] 1.65 [0.28] 0.059
Delta TMT, sec 63.8 [31.6] 61.7 [46.3] 0.735
CVLT immediate recall 44.8 [13.2] 48.3 [12.4] 0.102

Footnote:

*

p<0.05.

from the initial assessment of 400m to the time of symptom onset for cases and to the most recent visit for controls.

age at the most recent visit for controls.

TMT=Trail Making Test. CVLT=California Verbal Learning Test.